Natco Pharma standalone net profit declines 41.98% in the September 2020 quarter

Sales rise 4.63% to Rs 478.90 crore

Net profit of Natco Pharma declined 41.98% to Rs 70.90 crore in the quarter ended September 2020 as against Rs 122.20 crore during the previous quarter ended September 2019. Sales rose 4.63% to Rs 478.90 crore in the quarter ended September 2020 as against Rs 457.70 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales478.90457.70 5 OPM %18.8829.93 -PBDT114.90165.20 -30 PBT86.50143.60 -40 NP70.90122.20 -42

Powered by Capital Market - Live News